Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) is a publicly traded Healthcare sector company. As of August 4, 2026, OBIO trades at $4.27 with a market cap of $246.71M and a P/E ratio of -4.34. OBIO moved +3.76% today. Year to date, OBIO is +2.89%; over the trailing twelve months it is +59.33%. Its 52-week range spans $2.20 to $6.30. Analyst consensus is strong buy with an average price target of $11.40. Rallies surfaces OBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for OBIO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.27 |
| Market Cap | $246.71M |
| P/E Ratio | -4.34 |
| EPS | $-0.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.30 |
| 52-Week Low | $2.20 |
| Volume | 103.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $32.72M |
| Net Income | $-54.64M |
| Gross Margin | 99.46% |
6 analysts cover OBIO: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.40.